V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220007454 | 220011652 | 1.66 | 80 | Curative (C) | 2014-05-18 | 2014-05-18 | Carboplatin + Paclitaxel (3 weekly) | N | null | 220032447 | CARBOPLATIN + PACLITAXEL |
| 220007455 | 220011652 | 1.44 | 72 | Curative (C) | null | 2015-09-15 | IDARUBICIN + TRETINOIN | 02 | N | 220032447 | IDARUBICIN + TRETINOIN |
| 220007456 | 220011652 | 1.78 | 59.3 | Palliative (P) | 2014-09-30 | 2014-09-30 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 220032447 | CISPLATIN + GEMCITABINE |
| 220007457 | 220011652 | 1.64 | 84 | Curative (C) | 2017-06-24 | 2017-06-29 | AML 18 TRIAL | null | N | 220032447 | AML18 TRIAL |
| 220007458 | 220011652 | 1.71 | 98.8 | Curative (C) | 2013-05-16 | 2013-05-18 | Carboplatin + Paclitaxel (weekly) | N | N | 220032447 | CARBOPLATIN + PACLITAXEL |
| 220007459 | 220022163 | 1.67 | 0 | Curative (C) | 2016-03-15 | 2016-03-15 | AML18 PILOT TRIAL | Y | null | 220032464 | PILOT TRIAL |
| 220007463 | 220002938 | 1.65 | 44.8 | Disease modification (D) | 2017-03-31 | 2017-04-01 | AML16 DA 3+10 | N | N | 220032476 | AML16 TRIAL |
| 220007464 | 220002939 | 1.72 | 76 | Palliative (P) | 2013-03-27 | 2013-03-27 | Carboplatin + Paclitaxel (3 weekly) | 2 | N | 220032477 | CARBOPLATIN + PACLITAXEL |
| 220007467 | 220016269 | 1.7 | 95 | Palliative (P) | 2014-12-13 | 2014-12-13 | CISPLATIN + GEMCITABINE | 02 | N | 220032491 | CISPLATIN + GEMCITABINE |
| 220007468 | 220002941 | 1.65 | 54.4 | Disease modification (D) | 2017-08-02 | 2017-08-02 | AML16 DA 3+10 | N | N | 220032492 | AML16 TRIAL |
| 220007470 | 220016270 | 1.84 | 76 | Curative (C) | 2015-05-25 | 2015-05-25 | Dasatinib | 02 | N | 220032495 | DASATINIB |
| 220007471 | 220016270 | null | null | Curative (C) | 2015-05-08 | 2015-05-08 | Idarubicin+Tretinoin Spanish Crse2 | null | N | 220032495 | IDARUBICIN + TRETINOIN |
| 220007472 | 220016270 | 1.71 | null | Palliative (P) | 2015-09-02 | 2015-10-13 | CISPLATIN + GEMCITABINE | N | N | 220032495 | CISPLATIN + GEMCITABINE |
| 220007473 | 220002942 | 1.68 | 102.6 | Disease modification (D) | 2012-09-05 | 2012-09-05 | Dasatinib | 2 | N | 220032502 | DASATINIB |
| 220007474 | 220002942 | 1.63 | 55.95 | Curative (C) | 2014-08-18 | 2014-08-23 | AML 18 TRIAL | Y | N | 220032502 | AML18 TRIAL |
| 220007475 | 220016271 | 1.74 | 82 | Palliative (P) | 2014-12-19 | 2015-02-02 | Cisplatin+Gemcitabine (gallbladder) | null | N | 220032507 | CISPLATIN + GEMCITABINE |
| 220007476 | 220016271 | 1.86 | 101.7 | Curative (C) | 2017-11-20 | 2017-11-25 | AML 18 TRIAL | 01 | N | 220032507 | AML18 TRIAL |
| 220007477 | 220016271 | 1.69 | 79 | Neo-adjuvant (N) | 2016-05-26 | 2016-05-28 | AML 18 TRIAL | Y | null | 220032507 | AML18 TRIAL |
| 220007478 | 220016271 | null | null | Curative (C) | 2017-11-20 | 2017-11-23 | Carboplatin + Paclitaxel (3 weekly) | N | null | 220032507 | CARBOPLATIN + PACLITAXEL |
| 220007479 | 220016271 | 1.77 | 74.8 | null | null | 2017-12-10 | IDARUBICIN + TRETINOIN | N | null | 220032507 | IDARUBICIN + TRETINOIN |
| 220007480 | 220016271 | 1.67 | 78.1 | Disease modification (D) | 2013-07-21 | 2013-08-05 | AML16 DA 3+10 | Y | N | 220032507 | AML16 TRIAL |
| 220007481 | 220002943 | 1.8 | null | Curative (C) | 2015-08-16 | 2015-08-16 | AML16 Low Dose Cytarabine | Y | N | 220032520 | AML16 TRIAL |
| 220007483 | 220002945 | 1.79 | 0 | Curative (C) | 2015-09-13 | 2015-09-14 | AML16 DA 3+10 | N | Y | 220032522 | AML16 TRIAL |
| 220007484 | 220002946 | 1.8 | 113 | Curative (C) | 2014-12-23 | 2014-12-23 | AML 18 TRIAL | Y | N | 220032524 | AML18 TRIAL |
| 220007485 | 220002947 | 1.63 | 72 | Neo-adjuvant (N) | 2015-01-05 | 2015-02-14 | Carboplatin + Paclitaxel (weekly) | N | N | 220032527 | CARBOPLATIN + PACLITAXEL |
| 220007486 | 220002948 | null | null | Palliative (P) | 2015-07-04 | 2015-07-14 | CARBOPLATIN + PACLITAXEL | N | N | 220032528 | CARBOPLATIN + PACLITAXEL |
| 220007487 | 220002949 | 1.62 | 14.7 | Curative (C) | 2017-12-06 | 2018-01-15 | CARBOPLATIN + PACLITAXEL | null | N | 220032530 | CARBOPLATIN + PACLITAXEL |
| 220007488 | 220002949 | 1.79 | 64 | Palliative (P) | null | 2015-05-06 | CARBOPLATIN + PACLITAXEL | N | N | 220032530 | CARBOPLATIN + PACLITAXEL |
| 220007489 | 220002950 | 1.55 | null | Disease modification (D) | 2013-03-20 | 2013-03-20 | AML16 Low Dose Cytarabine | N | null | 220032533 | AML16 TRIAL |
| 220007490 | 220011658 | null | 52 | Palliative (P) | 2015-09-04 | 2015-09-11 | CISPLATIN + GEMCITABINE | null | null | 220032534 | CISPLATIN + GEMCITABINE |
| 220007491 | 220011658 | 150.7 | 50 | Curative (C) | 2014-12-28 | 2014-12-28 | IDARUBICIN + TRETINOIN | 2 | N | 220032534 | IDARUBICIN + TRETINOIN |
| 220007492 | 220011658 | 1.79 | 81.4 | Curative (C) | 2014-11-09 | 2014-11-10 | Dasatinib | 02 | N | 220032534 | DASATINIB |
| 220007493 | 220011658 | 1.69 | 0 | Curative (C) | 2012-03-22 | 2015-06-24 | AML18 PILOT TRIAL | N | N | 220032534 | PILOT TRIAL |
| 220007494 | 220002951 | 1.79 | 76 | Curative (C) | 2015-01-03 | 2015-01-10 | Dasatinib | null | N | 220032548 | DASATINIB |
| 220007497 | 220002953 | 1.71 | 82 | Palliative (P) | 2017-01-15 | 2017-02-16 | Carboplatin + Paclitaxel (3 weekly) | N | N | 220032556 | CARBOPLATIN + PACLITAXEL |
| 220007498 | 220011660 | 1.74 | 119 | Curative (C) | 2014-10-07 | 2014-10-07 | AML 18 TRIAL | Y | N | 220032558 | AML18 TRIAL |
| 220007499 | 220011660 | 1.63 | 78.7 | Palliative (P) | 2015-01-24 | 2015-01-25 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 220032558 | CISPLATIN + GEMCITABINE |
| 220007503 | 220002955 | null | 82.9 | Palliative (P) | 2015-01-10 | 2015-01-15 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 220032572 | CISPLATIN + GEMCITABINE |
| 220007504 | 220002955 | 1.52 | null | Disease modification (D) | 2014-12-03 | 2014-12-15 | Dasatinib | 02 | N | 220032572 | DASATINIB |
| 220007505 | 220002955 | null | 74.8 | Curative (C) | null | 2015-02-21 | IDARUBICIN + TRETINOIN | 02 | null | 220032572 | IDARUBICIN + TRETINOIN |
| 220007506 | 220002956 | null | null | Palliative (P) | 2013-01-22 | 2013-02-16 | Carboplatin + Paclitaxel (3 weekly) | 02 | null | 220032579 | CARBOPLATIN + PACLITAXEL |
| 220007507 | 220002957 | 1.63 | 81.7 | Curative (C) | 2014-01-26 | 2014-01-26 | AML 18 TRIAL | 1 | N | 220032582 | AML18 TRIAL |
| 220007508 | 220002957 | 1.75 | 88 | Curative (C) | null | 2016-07-01 | AML16 DA 3+10 | N | null | 220032582 | AML16 TRIAL |
| 220007509 | 220016276 | null | 106 | Disease modification (D) | 2017-11-09 | 2017-11-09 | AML16 DA 3+8 | N | N | 220032588 | AML16 TRIAL |
| 220007510 | 220002958 | 1.67 | 57 | Palliative (P) | 2014-11-23 | 2014-11-26 | Carboplatin + Paclitaxel (3 weekly) | N | N | 220032589 | CARBOPLATIN + PACLITAXEL |
| 220007511 | 220002959 | null | 68.4 | Curative (C) | 2015-02-17 | 2015-02-17 | IDARUBICIN + TRETINOIN | 02 | N | 220032592 | IDARUBICIN + TRETINOIN |
| 220007512 | 220002960 | 1.73 | 87.8 | Palliative (P) | 2014-06-11 | 2014-06-16 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 220032593 | CISPLATIN + GEMCITABINE |
| 220007513 | 220002961 | 1.59 | 93.4 | Palliative (P) | 2015-07-08 | 2015-07-09 | Cisplatin + Gemcitabine (D 1 & 8) | 2 | N | 220032596 | CISPLATIN + GEMCITABINE |
| 220007514 | 220002962 | 1.55 | 57 | Curative (C) | 2017-09-25 | 2017-09-25 | Carboplatin + Paclitaxel (weekly) | 2 | N | 220032598 | CARBOPLATIN + PACLITAXEL |
| 220007515 | 220002962 | 1.51 | 62 | Curative (C) | 2017-12-30 | 2018-01-01 | AML16 DA 3+10 | N | N | 220032598 | AML16 TRIAL |